Table 2.
Univariate Analysis of Clinical Factors of Renal Tubular DysFunction in PLWH Receiving TDF.
| Characteristics | OR (95% CI) | P value |
|---|---|---|
| Age | 0.98 (0.90-1.06) | 0.577 |
| Female gender | 1.17 (0.34-3.95) | 0.804 |
| BMI | 0.76 (0.59-0.97) | 0.027 |
| Duration TDF, per month increment | 1.01 (0.98- 1.06) | 0.359 |
| CD4 cell count, per 100 cells/mm3 increment | 1.14 (0.87 -1.50) | 0.340 |
| PI-containing regimen | 5.88 (1.38-25.01) | 0.017 |
| Hypertension | 1.43 (0.33- 6.28) | 0.633 |
| Hyperlipidemia | 3.95 (1.11-14.03) | 0.034 |
Abbreviations: BMI: body mass index, CI: confidence interval, TDF: tenofovir disoproxil fumarate, OR: odds ratio, PI: protease inhibitor.